Monthly Archives: January 2017

Top 5 Undervalued Stocks To Invest In Right Now

There are countless investing rules, mantras and cliches out there ranging from extremely useful to downright dangerous.

One of the most widely accepted and potentially detrimental to your portfolio is, “Buy low, sell high.”

When taken literally, of course, to make a profit you must sell a stock for more than you paid for it. But the essence of buy low, sell high has....More>>>

Sherwin-Williams Co – An Unsung Growth Hero

Some of the best long-term investments are in companies that don’t catch a ton of headlines because their business just isn’t that interesting. Sherwin-Williams Co (NYSE:SHW) is a perfect example of this. Following their acquisition of Valspar they will be the largest paint & coating company in the world, surpassing PPG Industries (NYSE:PPG). If I had to make a list of boring industries,....More>>>

how to invest

KBW’sFrederick Cannon andAllyson Boyd consider whether mega banks like Citigroup (C), Bank of America (BAC), Wells Fargo (WFC), JPMorgan Chase (JPM) and Morgan Stanley (MS) should be broken up:

Citigroup Center near Citibank headquarters in Manhattan Mario Tama/Getty Images

The debate over bank size is raging…Bernie Sanders has made it a focal point of his presidential....More>>>

penny stock screener

Kellyanne Conway Lets Advisors In on Secret of Trump Win

Trump Pick for DOL Chief Said to Be Andrew Puzder

What the Future of Social Security Looks Like: Bill Reichenstein

Besides continuing to focus on cybersecurity and elder financial fraud, worries about whether the SEC’s Investor Advisory Committee will continue to exist in 2017, and if the Department of Labor’s....More>>>

Top Biotech Stocks To Watch Right Now

Gilead Sciences (NSDQ:GILD)has been dedicating large capital for Research and Development(R&D) in the last few years. In fact, its R&D expenses for the trailing twelve months of $4,647 million have been the highest among all biotechnology companies, as shown in the table below. However, currently, Gilead is changing its research and development focus from hepatitis C drugs to other areas.....More>>>